Oxygen Protocols for The treatment of Myocardial Infarction: Mortality, Infarct Size & Efficacy

Not Applicable

Recruiting

• Conditions: Myocardial Infarction; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12607000500459
• Lead Sponsor: Medical Research Institute of New Zealand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-09-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Present with ST-segment elevation myocardial infarction (STEMI) based on established diagnostic criteria
Are at least 18 years of age and competent to provide written informed consent before entering the study. Informed consent must be signed by the study participant.

Exclusion Criteria

Severe Chronic Obstructive Pulmonary Disease (COPD) or other respiratory disease with PaCO2 > 45mm Hg;
Previous myocardial infarction;
Subjects who are not to be admitted to the coronary care unit;
Women who are known to be pregnant;
Cardiogenic shock at the time of presentation at hospital;
Severe arterial hypoxaemia (oxygen saturation less than/equal to 85%) at time of presentation;
Patients enrolled in other cardiology studies.; patients who have had previous treatment with bleomycin.

Study & Design

• Study Type: Interventional
• Study Design: Not specified